To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.
Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
Open to trying a non-combusted oral tobacco product.
Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
Plan to quit smoking in the next 30 days.
Use of smokeless tobacco at least weekly in the last 6 months.
Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
Unwilling or unable to follow protocol requirements.
Parallel
Modified Risk - None
BehavioralParticipants view ads with no modified risk claim
Modified Risk Claim
BehavioralParticipants view ads with a modified risk claim
Demand for cigarettes
After watching a series of advertisements for oral smokeless tobacco products, participants will provide opinions of them, including likelihood of buying product.
Increase in knowlege of tobacco-associated diseases
multi item assessment questionnaires of perceived harm/risks from products
Click on the lead sponsor to view all of their trials.
Roswell Park Cancer Institute
Lead sponsor
National Cancer Institute (NCI)
Collaborator
